Implantica AG
IMP-A-SDB.ST - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.62B
Close$
$-2.64
103.8% downside
Current Fair Value
103.8% downsideOvervalued by 103.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.62 Billion |
|---|---|
| Enterprise Value | $3.58 Billion |
| Earnings per Share | $-0.29 |
| Beta | 0.79 |
| Outstanding Shares | 69,602,574 |
Return
| Return on Equity | -25.27% |
|---|---|
| Return on Assets | -24.95% |
| Return on Invested Capital | -24.52% |
Valuation & Multiples
| P/E Ratio | -19.89 |
|---|---|
| PEG | 71.3 |
| Price to Sales | - |
| Price to Book Ratio | 69.0 |
| Enterprise Value to Revenue | 1460.8 |
| Enterprise Value to EBIT | -192.54 |
| Enterprise Value to Net Income | -182 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
$-0.80
Consensus analyst estimateRevenue Estimate
$8.20 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 19, 2026
EPS Estimate
$-0.90
Consensus analyst estimateRevenue Estimate
$11.30 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Implantica AG
46 employees
CEO: Peter Forsell
Implantica AG, a medical technology firm established in 2015 and based in Vaduz, Liechtenstein, specializes in the research, development, and commercialization of advanced medical implants. The company focuses on addressing critical, unm...